GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (FRA:NPAU) » Definitions » Short-Term Capital Lease Obligation

BetterLife Pharma (FRA:NPAU) Short-Term Capital Lease Obligation : €0.37 Mil (As of Jul. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Short-Term Capital Lease Obligation?

BetterLife Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Jul. 2024 was €0.37 Mil.

BetterLife Pharma's quarterly Short-Term Capital Lease Obligation declined from Jan. 2024 (€0.38 Mil) to Apr. 2024 (€0.38 Mil) and declined from Apr. 2024 (€0.38 Mil) to Jul. 2024 (€0.37 Mil).

BetterLife Pharma's annual Short-Term Capital Lease Obligation increased from Jan. 2022 (€0.15 Mil) to Jan. 2023 (€0.46 Mil) but then declined from Jan. 2023 (€0.46 Mil) to Jan. 2024 (€0.38 Mil).


BetterLife Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for BetterLife Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Short-Term Capital Lease Obligation Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.12 0.15 0.46 0.38

BetterLife Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 - 0.38 0.38 0.37

BetterLife Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


BetterLife Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma Business Description

Industry
Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma Headlines

No Headlines